|
|
|
|
|
Sponsors and Collaborators: |
University Health Network, Toronto Ontario Cancer Research Network |
Information provided by: | University Health Network, Toronto |
ClinicalTrials.gov Identifier: | NCT00188175 |
Intensity-modulated radiation therapy may make wound healing problems less likely by 1)precisely shaping the region of high radiation dose to the shape of the tissue which harbours tumour cells, and 2) precisely shaping the regions of low radiation dose to the shapes of the normal tissues which are more sensitive to radiation effects.
Condition | Intervention | Phase |
Sarcoma |
Radiation: Intensity Modulated Radiation Therapy |
Phase II |
MedlinePlus related topics: | Cancer Soft Tissue Sarcoma |
Study Type: | Interventional |
Study Design: | Prevention, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | A Phase II Study of Preoperative Intensity-Modulated Radiation Therapy For Lower Limb Soft Tissue Sarcoma |
Estimated Enrollment: | 60 |
Study Start Date: | May 2003 |
Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Experimental
Radiation
|
Radiation: Intensity Modulated Radiation Therapy
Pre-op Intensity Modulated Radiation Therapy for lower limb soft tissue sarcoma.
|
Ages Eligible for Study: | 16 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: O'Sullivan Brian, MD | 416-946-2125 | brian.o'sullivan@rmp.uhn.on.ca |
Canada, Ontario | |||||
Princess Margaret Hospital | Recruiting | ||||
Toronto, Ontario, Canada, M5G 2M9 | |||||
Contact: Brian O'Sullivan, MD 416-946-2125 brian.o'sullivan@rmp.uhn.on.ca |
University Health Network, Toronto |
Ontario Cancer Research Network |
Principal Investigator: | Brian O'Sullivan, MD | Princess Margaret Hospital, Canada |
Responsible Party: | University Health Network ( Dr. Brian O'Sullivan, Principal Investigator ) |
Study ID Numbers: | 03-0107-C |
First Received: | September 9, 2005 |
Last Updated: | January 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00188175 |
Health Authority: | Canada: Ethics Review Committee |
|
|